Cyclists rolled along the scenic roads of Chilliwack and Abbotsford on the weekend to raise money for multiple sclerosis.

When ocrelizumab became the first FDA-approved treatment for early forms of multiple sclerosis (MS) in 2017, it offered ...

Autoimmune diseases, such as multiple sclerosis (MS), inflammatory bowel disease (IBD), and rheumatoid arthritis (RA), affect ...

The University of Cincinnati joins a Phase 1 clinical trial testing CAR-T cell therapy for MS, exploring this cancer ...

While there is currently no cure for multiple sclerosis, researchers continue to discover clues to give a better ...

The rates of people MS advancing from RRMS to SPMS have decreased significantly in the past decades, according to a 30-year ...

Columnist Desiree Lama explores how living with MS led her to confront the comparison trap, ultimately finding strength in ...

Researchers from Mātai Medical Research Institute in Gisborne are helping develop a new MRI scan method, which they say can ...

Rocky Mountain MS Clinic opened a location in Lehi this week, filling a gap in care for patients who have traveled hours or ...

Teriflunomide matched ocrelizumab in controlling smoldering RRMS activity and showed a possible advantage in preserving brain ...

A new study reveals that neural stem cell grafts can generate new myelin in the central nervous system, offering hope for ...

Susan Blackborough was just 12 when she was diagnosed with multiple sclerosis and was told she would lose her ability to walk ...